Viewing Study NCT01836120

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:28 AM
Ignite Modification Date: 2026-03-09 @ 4:06 AM
Study NCT ID: NCT01836120
Status: UNKNOWN
Last Update Posted: 2013-04-19
First Post: 2013-04-17
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study of Raltitrexed Plus Docetaxel Versus Docetaxel as Second-line Chemotherapy in Subjects With Gastric Cancer
Sponsor: Hebei Tumor Hospital
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Gastric Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None second-line chemotherapy View
None Raltitrexed View